Outsourcing facilities have until March 19, 2025, for tirzepatide and May 22, 2025, for GLP-1s
2 By aligning with manufacturers like Lilly and Novo Nordisk, Ro avoids the legal friction of mass-compounding while offering branded GLP-1 medications at price points engineered to undercut the compounded market
The combination isn't FDA-approved and is only available through research studies with strict eligibility criteria
GLP-1-Aware Oura Advisor Oura Advisor now understands your GLP-1 medication as context for your personal health journey
Because this blend influences multiple biological processes, medical supervision is essential to ensure appropriate use and monitor for any individual sensitivities
Member Services Member Programs As a Blue Cross and Blue Shield of Illinois member, you have access to tools and resources that can help you meet your health and wellness goals, save money and get care when you need it most